Sherezade Moñino-Romero

9PUBLICATIONS
31CO-AUTHORS
AllergyCancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 12, 2026
Isolated Mast Cell-Mediated Angioedema: Clinically Different but Endotypically Similar to Chronic Spontaneous Urticaria.

Thomas Buttgereit, Claudia Hayford, Carolina Vera Ayala

|Oct 28, 2025
Release of Mast Cell Mediators from Cochlear Tissue Following Short Exposure to Compound 48/80 or Cisplatin, and Their Damage to Cochlear Structure.

Bin Zeng, Stefan Frischbutter, Sherezade Moñino-Romero

|May 29, 2025
Depletion of mast cells with barzolvolimab, an anti-KIT antibody, does not affect mast cell progenitors.

Sherezade Moñino-Romero, Niklas Amadeus Mahnke, Dorothea Terhorst-Molawi

|Aug 29, 2023
Elevated baseline soluble FcεRI may be linked to early response to omalizumab treatment in chronic spontaneous urticaria.

S Moñino-Romero, P Kolkhir, T Ohanyan

|Feb 24, 2023
Soluble IgE-binding factors in the serum of food-allergic patients: Possible pathophysiological role of soluble FcεRI as protective factor.

Carolin Steinert, Sherezade Moñino-Romero, Monique Butze

|Feb 17, 2022
Bruton's tyrosine kinase inhibition-An emerging therapeutic strategy in immune-mediated dermatological conditions.

Pedro Mendes-Bastos, Ana Brasileiro, Pavel Kolkhir

Pageof 2

Frequent Collaborators

5 joint publications

Jörg Scheffel

5 joint publications

Marcus Maurer

3 joint publications

Pavel Kolkhir

3 joint publications

Sabine Altrichter